Aimz Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Aimz Investment Advisors, LLC

$289 Million
Q3 2024

A detailed history of Aimz Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 21,260 shares of VRTX stock, worth $8.73 Million. This represents 3.42% of its overall portfolio holdings.

Number of Shares

21,260

Previous 21,466 0.96%

Holding current value

$8.73 Million

Previous $10.1 Million 1.73%

% of portfolio

3.42%

Previous 3.65%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $94,760 - $104,190	-206 Reduced 0.96%	21,260 $9.89 Million
Q2 2024 Aug 07, 2024	SELL	$392.81 - $485.53 $137,483 - $169,935	-350 Reduced 1.6%	21,466 $10.1 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $193,652 - $211,888	-475 Reduced 2.13%	21,816 $9.12 Million
Q4 2023 Jan 26, 2024	SELL	$343.0 - $410.68 $90,895 - $108,830	-265 Reduced 1.17%	22,291 $9.07 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $18,261 - $19,572	-54 Reduced 0.24%	22,556 $7.84 Million
Q2 2023 Aug 08, 2023	SELL	$314.42 - $351.91 $18,865 - $21,114	-60 Reduced 0.26%	22,610 $7.96 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $52,397 - $59,773	-185 Reduced 0.81%	22,670 $7.14 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $64,296 - $72,333	-225 Reduced 0.97%	22,855 $6.6 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $17,798 - $19,859	-65 Reduced 0.28%	23,080 $6.68 Million
Q2 2022 Aug 02, 2022	SELL	$234.96 - $292.55 $5,874 - $7,313	-25 Reduced 0.11%	23,145 $6.52 Million
Q1 2022 May 06, 2022	SELL	$221.42 - $260.97 $201,492 - $237,482	-910 Reduced 3.78%	23,170 $6.05 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $70,804 - $89,380	400 Added 1.69%	24,080 $5.29 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $2.9 Million - $3.25 Million	16,005 Added 208.53%	23,680 $4.3 Million
Q2 2021 Aug 05, 2021	BUY	$187.49 - $221.1 $28,123 - $33,165	150 Added 1.99%	7,675 $1.55 Million
Q1 2021 Apr 28, 2021	BUY	$207.02 - $241.31 $1.56 Million - $1.82 Million	7,525 New	7,525 $1.62 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.

Account

Aimz Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History